STAAR Surgical Company
STAA
$25.26
-$0.61-2.36%
NASDAQ
| 06/27/2025 | 03/28/2025 | 12/27/2024 | 09/27/2024 | 06/28/2024 | |
|---|---|---|---|---|---|
| Revenue | -55.23% | -44.94% | -35.82% | 10.31% | 7.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -55.23% | -44.94% | -35.82% | 10.31% | 7.26% |
| Cost of Revenue | -44.05% | -10.64% | 11.28% | 20.59% | -4.57% |
| Gross Profit | -58.17% | -54.12% | -47.88% | 7.62% | 10.87% |
| SG&A Expenses | -13.54% | -1.70% | 24.88% | 5.28% | 8.46% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -20.75% | -2.89% | 19.23% | 12.00% | 4.05% |
| Operating Income | -306.08% | -1,464.98% | -334.83% | -9.39% | 38.33% |
| Income Before Tax | -350.77% | -2,364.31% | -320.79% | 95.06% | 21.69% |
| Income Tax Expenses | -408.05% | -124.38% | -34.92% | 64.80% | 21.71% |
| Earnings from Continuing Operations | -327.84% | -1,523.57% | -541.31% | 107.18% | 21.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -327.84% | -1,523.57% | -541.31% | 107.18% | 21.69% |
| EBIT | -306.08% | -1,464.98% | -334.83% | -9.39% | 38.33% |
| EBITDA | -268.18% | -3,203.68% | -294.88% | -2.37% | 33.55% |
| EPS Basic | -326.03% | -1,508.49% | -537.26% | 104.64% | 19.97% |
| Normalized Basic EPS | -298.33% | -1,324.38% | -298.66% | 92.85% | 19.98% |
| EPS Diluted | -326.67% | -1,471.43% | -537.26% | 101.82% | 25.00% |
| Normalized Diluted EPS | -301.08% | -1,324.38% | -300.42% | 93.68% | 20.99% |
| Average Basic Shares Outstanding | 0.80% | 0.89% | 0.92% | 1.21% | 1.46% |
| Average Diluted Shares Outstanding | -0.58% | 0.89% | 0.05% | 0.73% | 0.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |